Institutional Biosafety Committee (IBC)For Biological and Recombinant Work

Principal Investigators are required to submit a Notification of Use (NOU) for Biological Agents, recombinant material, Human and Non-Human Primate Products for Institutional Biosafety Committee (IBC) approval prior to any work being conducted. Materials that require IBC approval prior to work commencing are the following:

  • All human and non-human primate material (including commercial cell lines)
  • All risk group 2-3-4 infectious agents
  • All recombinant material (purchased or manipulated) regulated by NIH-OBA guidelines

Addition of new agents to existing protocol is not permitted a new NOU must be submitted.
Principal Investigators are responsible for the following:

  • Submitting a new NOU to the IBC prior to new agent or recombinant material being used.
  • Maintaining list of current personnel for each of their NOU.
  • Maintaining current NOU for work being conducted in their laboratories (renewal every 5 years).
  • Notifying the IBC of changes:
  • Submitting NOU and NIH-OBA update forms yearly
  • For using the most current version of NOU to submit to the IBC, failure to do so may result in the NOU not being approved and delaying the commencement of the project.

IBC Guidelines for SARS-CoV-2
(COVID-19)

  IBC Memo  
  Guidelines  

St. Louis Encephalitis Virus & West Nile Virus Biosafety Level Requirements
   

The IBC meets each first Friday of the month.  All paperwork must be provided to EHS Biosafety Program two weeks prior to the meeting by campus mail to Rt. #1111 or by email to EHS.IBC@utmb.edu.  Contact the Biosafety Program at (409) 772-1781 if you have questions.

Main Documents:
Notification of Use - EHSA Form 

  • Google Chrome is the preferred Internet browser with EHSA
  • Follow the link above for instructions or to assign a proxy

Personnel Experience Table Form  (Rev. 8-16)

EHSA Presentation for NOU (New 7-20)

NOU Subm Deadlines FY20 (3)

Amendment form to existing NOU: 
Human and/or Non-human Primate Products Amendment Form *
    * Use this link for NOUs approved after 4/6/2018
     If approved prior to 4/6/2018, send a cover letter summarizing the changes to EHS.IBC@utmb.edu or
     contact EHS at 409-772-1781
Keck and Optical Microscopy Core Facilities NOU Amendment Form  (Revised 02-15)
Aerobiology Facility Amendment Form  (Revised 02-15)
Recombinant Materials Amendment Form  (Revised 12-17)
Arthropod Section Amendment Form  (Revised 11-16)
Animal Section Amendment Form  (Revised 12-16)

Other documents:
Add/Delete Personnel on Existing NOU Form * (Revised 10-18)
     * Only for NOUs approved prior to May 2018  
       NOUs approved after May 1, 2018, must log into EHSA and submit an amendment
Special Immunization Request Form  (Use for FDA approved vaccines)
Co-PI Cover Page Form  (Revised 02-15)
Viral Vector Guidance Document
IBC NOU Policy
Standard Precautions Courses  (Required for Human and/or Non-Human Primate Products NOUs)

Risk Assessment for Special Immunization Request Form 1 and Form 2  (Use for IND/Global vaccines)